Advertisement

Journal of General Internal Medicine

, Volume 33, Issue 7, pp 1077–1083 | Cite as

HPV Self-Sampling for Cervical Cancer Screening Among Ethnic Minority Women in South Florida: a Randomized Trial

  • Olveen Carrasquillo
  • Julia Seay
  • Anthony Amofah
  • Larry Pierre
  • Yisel Alonzo
  • Shelia McCann
  • Martha Gonzalez
  • Dinah Trevil
  • Tulay Koru-Sengul
  • Erin Kobetz
Original Research

Abstract

Background

Ethnic minority women are at increased risk of cervical cancer. Self-sampling for high-risk human papillomavirus (HPV) is a promising approach to increase cervical screening among hard-to-reach populations.

Objective

To compare a community health worker (CHW)-led HPV self-sampling intervention with standard cervical cancer screening approaches.

Design

A 26-week single-blind randomized pragmatic clinical trial.

Participants

From October 6, 2011 to July 7, 2014, a total of 601 Black, Haitian, and Hispanic women aged 30–65 years in need of cervical cancer screening were recruited, 479 of whom completed study follow-up.

Interventions

Participants were randomized into three groups: (1) outreach by CHWs and provision of culturally tailored cervical cancer screening information (outreach), (2) individualized CHW-led education and navigation to local health care facilities for Pap smear (navigation), or (3) individualized CHW-led education with a choice of HPV self-sampling or CHW-facilitated navigation to Pap smear (self-swab option).

Main Measures

The proportion of women in each group whom self-reported completion of cervical cancer screening. Women lost to follow-up were considered as not having been screened.

Key Results

Of the 601 women enrolled, 355 (59%) were Hispanic, 210 (35%) were Haitian, and 36 (6%) were non-Haitian Black. In intent-to-treat analyses, 160 of 207 (77%) of women in the self-swab option group completed cervical cancer screening versus 57 of 182 (31%) in the outreach group (aOR 95% CI, p < 0.01) and 90 of 212 (43%) in the navigation group (aOR CI, p = 0.02).

Conclusions

As compared to more traditional approaches, CHW-facilitated HPV self-sampling led to increased cervical cancer screening among ethnic minority women in South Florida.

Trial Registration

Clinical Trials.gov Identifier: NCT02121548

Notes

Acknowledgements

We wish to thank our study team staff having a critical role in ensuring completion of the study. These include our community health workers, Valentine Cesar (center for Haitian Studies), Maria Azqueta (Citrus Health), and Linabell Lopez (Community Health Inc.); data management and analysis team including Carmen Linarte and Feng Miao; and prior project coordinator Brendaly Rodriguez.

Financial Support

This work was supported by the National Cancer Institute Community Networks Program Center Grant U54 CAI53705.

Compliance with Ethical Standards

The study was approved by the University of Miami Institutional Review Board and registered at clinialtrials.gov (NCT02121548). During this visit, participants provided free and voluntary informed consent in their primary language (English, Spanish, or Haitian Creole) and had all of their questions answered prior to signing.

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Supplementary material

11606_2018_4404_MOESM1_ESM.docx (25 kb)
ESM 1 (DOCX 24 kb)

References

  1. 1.
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2016. Available at: www.cdc.gov/uscs. Accessed February 2, 2018.
  2. 2.
    Beavis, AL, Gravitt PE, Rositch AF. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer 2017;123:1044–1050.CrossRefPubMedGoogle Scholar
  3. 3.
    Musselwhite W, Oliveira CM, Kwaramba T, et al. Racial/ethnic disparities in cervical cancer screening and outcomes. Acta Cytologica 2016;60:518–526.CrossRefPubMedGoogle Scholar
  4. 4.
    Lin L, Benard VB, Greek A, Hawkins NA, Roland KB, Saraiya M. Racial and ethnic differences in human papillomavirus positivity and risk factors among low-income women in Federally Qualified Health Centers in the United States. Prev Med. 2015;81:258–61.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Seay JS, Carrasquillo O, Campos NG, McCann S, Amofah A, Pierre L, et al. Cancer screening utilization among immigrant women in Miami, Florida. Progress in Community Health Partnerships: Research, Education, and Action. 2015;9 Suppl:11–20.CrossRefGoogle Scholar
  6. 6.
    Downs LS, Smith JS, Scarinci I, Flowers L, Parham G. The disparity of cervical cancer in diverse populations. Gynecologic Oncology 2008;109;S22–S30.CrossRefPubMedGoogle Scholar
  7. 7.
    O’Brien MJ, Halbert CH, Bixby R, Susana Pimentel S, Shea J. Community health worker intervention to decrease cervical cancer disparities in Hispanic women. J Gen Intern Med. 2010; 25: 1186–1192.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    National Cancer Institute. Research-tested Intervention Programs (RTIPs): cervical cancer Available from: https://rtips.cancer.gov/rtips/programSearch.do Accessed February 2, 2018
  9. 9.
    Community Preventive Services Task Force. Updated recommendations for client- and provider-oriented interventions to increase breast, cervical, and colorectal cancer screening. Am J Prev Med 2012;43:760–4.Google Scholar
  10. 10.
    Ronco G, Dillner J, Elfström KM, et al: Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials. Lancet 2014;383:524–32.CrossRefPubMedGoogle Scholar
  11. 11.
    Jeronimo J, Castle PE, Temin S et al. Secondary prevention of cervical cancer: ASCO Resource-Stratified Clinical Practice Guideline. J Glob Oncol 2017;3:635–657.CrossRefPubMedGoogle Scholar
  12. 12.
    US Food and Drug Administration. Meeting materials of the microbiology devices panel. 12 March 2014. FDA, Bethesda, MD. https://wayback.archive-it.org/7993/20170113191702/http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/MicrobiologyDevicesPanel/UCM388564.pdf. Accessed February 2, 2018.
  13. 13.
    Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15:172–83.CrossRefPubMedGoogle Scholar
  14. 14.
    Belinson JL, Du H, Yang B, Wu R, Belinson SE, Qu X, et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer. 2012;130:1855–60.CrossRefPubMedGoogle Scholar
  15. 15.
    Racey CS, Withrow DR, Gesink D: Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health 2013;104:e159-e166.PubMedGoogle Scholar
  16. 16.
    Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening program by offering self-sampling kits: a systematic review and meta-analysis of randomized trials. Eur J Cancer. 2015;51:2375–85.CrossRefPubMedGoogle Scholar
  17. 17.
    Barbee L, Kobetz E, Menard J, Cook N, Blanco J, Barton B, et al. Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes & Control. 2010;21:421–31.CrossRefGoogle Scholar
  18. 18.
    Castle PE, Rausa A, Walls T, Gravitt PE, Partridge EE, Olivo V, et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med 2011;52:452–55.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Ilangovan K, Erin Kobetz E, Koru-Sengul T, et al. Acceptability and feasibility of human papilloma virus self-sampling for cervical cancer screening. Journal Women’s Health 2016;25: 944–51.CrossRefGoogle Scholar
  20. 20.
    Sewali B, Okuyemi KS, Askhir A, et al. Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial. Cancer Med. 2015;4: 620–631.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Carrasquillo O, McCann S, Amofah A, et al. Rationale and Design of the Research Project of the South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS): study protocol for a randomized controlled trial. Trials. 2014;15:e299.CrossRefGoogle Scholar
  22. 22.
    Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the U.S. know about human papillomavirus (HPV) and cervical cancer? Cancer Epidemiology, Biomarkers, and Prevention, 2007;16:288–94.CrossRefGoogle Scholar
  23. 23.
    Hariri S, Unger ER, Strenberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006. J Infect Dis 2011:204:566–573.CrossRefPubMedGoogle Scholar
  24. 24.
    Lazcano-Ponce E, Lorincz A, Cruz-Valdez et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomized controlled trial. Lancet 2011: 378;1868–1873.CrossRefPubMedGoogle Scholar
  25. 25.
    Arrossi S, Thouyaret L, Herrero R, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomized trial. Lancet Glob Health, 2015;3:e85–94.CrossRefPubMedGoogle Scholar
  26. 26.
    Montaño DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. American Journal of Public Health 1995:85;795–800.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Han JJ, Beltran TH, Song JW. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men National Health and Nutrition Examination Survey (NHANES) 2013-2014. JAMA Oncol 2017;3:810–816.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Society of General Internal Medicine 2018

Authors and Affiliations

  • Olveen Carrasquillo
    • 1
    • 2
    • 3
  • Julia Seay
    • 2
    • 3
  • Anthony Amofah
    • 4
  • Larry Pierre
    • 5
  • Yisel Alonzo
    • 1
  • Shelia McCann
    • 4
  • Martha Gonzalez
    • 3
  • Dinah Trevil
    • 3
  • Tulay Koru-Sengul
    • 2
    • 3
  • Erin Kobetz
    • 1
    • 2
    • 3
  1. 1.Department of Medicine, Public Health SciencesUniversity of Miami Miller School of MedicineMiamiUSA
  2. 2.Department of Medicine, Sylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiamiUSA
  3. 3.Department of MedicineUniversity of Miami Miller School of MedicineMiamiUSA
  4. 4.Health Choice NetworkMiami-Dade CountyUSA
  5. 5.Center for Haitian StudiesMiami-Dade CountyUSA

Personalised recommendations